14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.579 $0.81 Thursday, 2nd May 2024 CMMB stock ended at $0.735. This is 1.35% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.24% from a day low at $0.667 to a day high of $0.735.
90 days $0.550 $0.88
52 weeks $0.420 $1.89

Historical Chemomab Therapeutics Ltd. prices

Date Open High Low Close Volume
May 02, 2024 $0.726 $0.735 $0.667 $0.735 12 160
May 01, 2024 $0.670 $0.725 $0.657 $0.725 60 167
Apr 30, 2024 $0.674 $0.720 $0.674 $0.700 12 385
Apr 29, 2024 $0.620 $0.690 $0.620 $0.680 19 959
Apr 26, 2024 $0.631 $0.646 $0.620 $0.640 23 537
Apr 25, 2024 $0.670 $0.680 $0.633 $0.659 11 538
Apr 24, 2024 $0.680 $0.680 $0.650 $0.670 3 334
Apr 23, 2024 $0.680 $0.680 $0.647 $0.670 7 099
Apr 22, 2024 $0.665 $0.665 $0.622 $0.660 9 520
Apr 19, 2024 $0.740 $0.740 $0.657 $0.680 15 392
Apr 18, 2024 $0.620 $0.700 $0.620 $0.700 29 623
Apr 17, 2024 $0.694 $0.695 $0.579 $0.590 47 833
Apr 16, 2024 $0.700 $0.740 $0.660 $0.661 38 165
Apr 15, 2024 $0.751 $0.770 $0.720 $0.730 50 207
Apr 12, 2024 $0.750 $0.790 $0.750 $0.770 11 601
Apr 11, 2024 $0.790 $0.790 $0.755 $0.760 37 688
Apr 10, 2024 $0.790 $0.80 $0.775 $0.790 12 995
Apr 09, 2024 $0.790 $0.80 $0.780 $0.790 15 602
Apr 08, 2024 $0.800 $0.800 $0.780 $0.791 72 925
Apr 05, 2024 $0.770 $0.80 $0.770 $0.80 35 678
Apr 04, 2024 $0.790 $0.80 $0.760 $0.780 43 366
Apr 03, 2024 $0.780 $0.81 $0.748 $0.81 55 235
Apr 02, 2024 $0.768 $0.770 $0.740 $0.762 16 432
Apr 01, 2024 $0.780 $0.790 $0.760 $0.771 33 959
Mar 28, 2024 $0.770 $0.780 $0.750 $0.779 28 500
Click to get the best stock tips daily for free!

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha... CMMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT